The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Clinical impact of serum proteins on drug delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peters, T. (1985) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60065-0 · Cited by 2,181
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Self-citationCrystal structure of human serum albumin at 2.5 Å resolution
Sugio, S., Kashima, A., Mochizuki, S., Noda, M., & Kobayashi, K. (1999) · Protein Engineering, Design and Selection · doi:10.1093/protein/12.6.439 · Cited by 1,786
The extraordinary ligand binding properties of human serum albumin
Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., Notari, S., & Ascenzi, P. (2005) · IUBMB Life (International Union of Biochemistry and Molecular Biology: Life) · doi:10.1080/15216540500404093 · Cited by 1,086
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
Impact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 832
Self-citationChanges in plasma protein binding have little clinical relevance
Benet, L. Z., & Hoener, B. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.121829 · Cited by 825
Protein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
Chaudhury, C., Mehnaz, S., Robinson, J. M., Hayton, W. L., Pearl, D. K., Roopenian, D. C., & Anderson, C. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021829 · Cited by 640
Predicting plasma protein binding of drugs: a new approach
Kratochwil, N. A., Huber, W., Müller, F., Kansy, M., & Gerber, P. R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01074-2 · Cited by 553
Laske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 525
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
Self-citationGlucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
Drucker, D. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0306 · Cited by 483
Tumor scanning with 67Ga citrate.
Edwards, C. L., & Hayes, R. L. (1969) · PubMed · Cited by 468
Transferrin/transferrin receptor‐mediated drug delivery
Li, H., & Qian, Z. M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10008 · Cited by 441
Desai, N., Trieu, V., Damascelli, B., & Soon-Shiong, P. (2009) · Translational Oncology · doi:10.1593/tlo.09109 · Cited by 396
Tiruppathi, C., Song, W., Bergenfeldt, M., Sass, P., & Malik, A. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25968 · Cited by 391
Bertucci, C., & Domenici, E. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023369673 · Cited by 354
Gradishar, W. J., Krasnojon, D., Cheporov, S., Makhson, A. N., Manikhas, G. M., Clawson, A., & Bhar, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5397 · Cited by 341
Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial Cells
Wang, Z., Tiruppathi, C., Minshall, R. D., & Malik, A. B. (2009) · ACS Nano · doi:10.1021/nn9012274 · Cited by 319
Stehle, G., Sinn, H., Wunder, A., Schrenk, H. H., Stewart, J. C. M., Hartung, G., Maier-Borst, W., & Heene, D. L. (1997) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(97)00015-2 · Cited by 305
Coppieters, K., Dreier, T., Silence, K., Haard, H. D., Lauwereys, M., Casteels, P., Beirnaert, E., Jonckheere, H., Wiele, C. V. D., Staelens, L., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21827 · Cited by 303
Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas
Weaver, M., & Laske, D. W. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1026246500788 · Cited by 299
Albumin Binding to FcRn: Distinct from the FcRn−IgG Interaction
Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M., & Anderson, C. L. (2006) · Biochemistry · doi:10.1021/bi052628y · Cited by 290
Kratz, F., Warnecke, A., Scheuermann, K., Stockmar, C., Schwab, J., Lazar, P., Drückes, P., Esser, N., Drevs, J., Rognan, D., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020276c · Cited by 275
Self-citationSage, H., Johnson, C., & Bornstein, P. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43194-2 · Cited by 265
Mansour, A. M., Drevs, J., Esser, N., Hamada, F. M. A., Badary, O. A., Unger, C., Fichtner, I., & Kratz, F. (2003) · PubMed · Cited by 239
Self-citationLentz, F., Drescher, A., Lindauer, A., Henke, M., Hilger, R. A., Hartinger, C. G., Scheulen, M. E., Dittrich, C., Keppler, B. K., & Jaehde, U. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328322fbc5 · Cited by 239
Podhajcer, O. L., Benedetti, L. G., Girotti, M. R., Prada, F., Salvatierra, E., & Llera, A. S. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9146-7 · Cited by 236
Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis
Wunder, A., Müller-Ladner, U., Stelzer, E. H. K., Funk, J., Neumann, E., Stehle, G., Pap, T., Sinn, H., Gay, S., & Fiehn, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4793 · Cited by 220
Schnitzer, J. E. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.1.h246 · Cited by 217
Development and Characterization of a Glucagon-Like Peptide 1-Albumin Conjugate
Kim, J.-G., Baggio, L. L., Bridon, D. P., Castaigne, J.-P., Robitaille, M. F., Jetté, L., Benquet, C., & Drucker, D. J. (2003) · Diabetes · doi:10.2337/diabetes.52.3.751 · Cited by 210
The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.
Kratz, F., Hartmann, M., Keppler, B., & Messori, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41984-3 · Cited by 204
Self-citationMadsbad, S., Kielgast, U., Asmar, M., Deacon, C. F., Torekov, S. S., & Holst, J. J. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01357.x · Cited by 202
Kratz, F., Müller-Driver, R., Hofmann, I., Drevs, J., & Unger, C. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9905864 · Cited by 166
Self-citationTargeted Delivery Systems for Oligonucleotide Therapeutics
Yu, B., Zhao, X., Lee, L. J., & Lee, R. J. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9096-1 · Cited by 158
Serum Proteins as Drug Carriers of Anticancer Agents: A Review
Kratz, F., & Beyer, U. (1998) · Drug Delivery · doi:10.3109/10717549809065759 · Cited by 156
Self-citationBaggio, L. L., Huang, Q., Cao, X., & Drucker, D. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.017 · Cited by 137
Hall, D. R., Hadden, J. M., Leonard, G. A., Bailey, S., Neu, M., Winn, M., & Lindley, P. F. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444901017309 · Cited by 113
Phase I and Pharmacokinetic Study of the (6-Maleimidocaproyl)Hydrazone Derivative of Doxorubicin
Unger, C., Häring, B., Medinger, M., Drevs, J., Steinbild, S., Kratz, F., & Mross, K. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2776 · Cited by 104
Self-citationThe loading rate determines tumor targeting properties of methotrexate albumin conjugates in rats
Stehle, G., Sinn, H., Wunder, A., Schrenk, H. H., tt, S. S., Maier‐Borst, W., & Heene, D. L. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199708000-00006 · Cited by 103
Nelson, D. R., Benhamou, Y., Chuang, W., Lawitz, E., Rodriguez‐Torres, M., Flisiak, R., Rasenack, J. W. F., Kryczka, W., Lee, C., Bain, V. G., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.062 · Cited by 98
Testa, U., Pelosi, E., & Peschle, C. (1993) · PubMed · Cited by 97
Gallium nitrate: the second metal with clinical activity.
Foster, B. J., Clagett-Carr, K., Hoth, D. F., & Leyland-Jones, B. (1986) · PubMed · Cited by 93
Hartung, G., Stehle, G., Sinn, H., Wunder, A. P., Schrenk, H. H., Heeger, S., Kränzle, M., Edler, L., Frei, E., Fiebig, H., et al. (1999) · PubMed · Cited by 88
Safety and Efficacy of nab -Paclitaxel in the Treatment of Patients with Breast Cancer
Vishnu, P., & Roy, V. (2011) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s5857 · Cited by 83
Bolling, C., Graefe, T., Lübbing, C., Jankevičius, F., Uktveris, S., Česas, A., Meyer‐Moldenhauer, W., Starkmann, H., Weigel, M. T., Burk, K., et al. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-8221-6 · Cited by 77
Vis, A. N., van der Gaast, A., van Rhijn, B., Catsburg, T., Schmidt, C., & Mickisch, G. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0417-z · Cited by 75
Pharmacokinetics of methotrexate???albumin conjugates in tumor-bearing rats
Stehle, G., Wunder, A., Sinn, H., Schrenk, H. H., Schiitt, S., Frei, E., Hartung, G., Maier‐Borst, W., & Heene, D. L. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199710000-00004 · Cited by 74
Zeuzem, S., Sulkowski, M., Lawitz, E., Rustgi, V. K., Rodriguez‐Torres, M., Bacon, B. R., Grigorescu, M. D., Tice, A. D., Lurie, Y., Cianciara, J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.066 · Cited by 72
Graeser, R., Esser, N., Unger, H., Fichtner, I., Zhu, A., Unger, C., & Kratz, F. (2009) · Investigational New Drugs · doi:10.1007/s10637-008-9208-2 · Cited by 70
Self-citationDhabuwala, A., Lamerton, P., & Stubbs, R. S. (2005) · BMC Nuclear Medicine · doi:10.1186/1471-2385-5-7 · Cited by 62
Hoff, D. D. V., Ramanathan, R. K., Borad, M. J., Laheru, D. A., Smith, L., Wood, T., Korn, R. L., Desai, N. P., Iglesias, J., & Hidalgo, M. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.4525 · Cited by 61
Prakash, J., de Jong, E., Post, E., Gouw, A. S. H., Beljaars, L., & Poelstra, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.018 · Cited by 55
Bansal, R., Prakash, J., de Ruijter, M., Beljaars, L., & Poelstra, K. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200263q · Cited by 51
FIUME, L., Bolondi, L., Busi, C., Chieco, P., Kratz, F., Lanza, M., Mattioli, A., & Stefano, G. D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.045 · Cited by 50
Self-citationRink, T., Heuser, T., Fitz, H., Schroth, H.-J., Weller, E., & Zippel, H. H. (2001) · Clinical Nuclear Medicine · doi:10.1097/00003072-200104000-00002 · Cited by 50
Temming, K., Meyer, D. L., Zabinski, R. F., Senter, P. D., Poelstra, K., Molema, G., & Kok, R. J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0700312 · Cited by 45
Elsadek, B., Graeser, R., Warnecke, A., Unger, C., Saleem, T. H., El-Melegy, N. T., Madkor, H. R., & Kratz, F. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100060m · Cited by 41
Self-citationKim, I., Kim, T. H., Ma, K., Lee, E. S., Kim, D., Oh, K. T., Lee, D. H., Lee, K. C., & Youn, Y. S. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100143c · Cited by 41
Defining the Role of Insulin Detemir in Basal Insulin Therapy
Morales, J. (2007) · Drugs · doi:10.2165/00003495-200767170-00007 · Cited by 39
Garg, S. K. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0127 · Cited by 38
Rašlová, K. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s10397 · Cited by 38
Metal Complexes as Antitumour Agents
Keppler, B. K., BERGER, M. R., Klenner, T., & Heim, M. (1990) · Advances in Drug Research · doi:10.1016/b978-0-12-013319-2.50008-5 · Cited by 34
Suga, K., Kume, N., Matsunaga, N., Motoyama, K., Hara, A., & Ogasawara, N. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000418 · Cited by 33
On-Site Preparation of Technetium-99m Labeled Human Serum Albumin for Clinical Application
Wang, Y., Chuang, M., Chiu, J.-S., et al. (2007) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.211.379 · Cited by 26
Neutral lipids production, transport, utilization.
Cantàfora, A., & Blotta, I. (1996) · PubMed · Cited by 18
Henry, D. H., & Dahl, N. V. (2007) · Community Oncology · doi:10.1016/s1548-5315(11)70057-2 · Cited by 18
Adams, B. K., Attia, H. M. A., KHADIM, R. A., & HAIDER, Z. Y. A. (2001) · Nuclear Medicine Communications · doi:10.1097/00006231-200103000-00008 · Cited by 16
Usefulness of Technetium-99m Human Serum Albumin Lymphoscintigraphy in Chyluria
Nishiyama, Y., Yamamoto, Y., Mori, Y., Satoh, K., Takashima, H., Ohkawa, M., & Tanabe, M. (1998) · Clinical Nuclear Medicine · doi:10.1097/00003072-199807000-00006 · Cited by 14
Characterization and in vitro/in vivo dissolution of nab-paclitaxel nanoparticles
Desai, N. P., De, T., Ci, S., Louie, L. G., & Trieu, V. N. (2008) · Cancer Research · Cited by 9
Cited by
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
The therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749
Molecularly Imprinted Polymers: Antibody Mimics for Bioimaging and Therapy
Haupt, K., Medina Rangel, P. X., & Bui, B. T. S. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00428 · Cited by 561
Albumin and its application in drug delivery
Sleep, D. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.993313 · Cited by 464
Albumin nanostructures as advanced drug delivery systems
Karimi, M., Bahrami, S., Ravari, S. B., Zangabad, P. S., Mirshekari, H., Bozorgomid, M., Shahreza, S., Sori, M., & Hamblin, M. R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1193149 · Cited by 422
Metadata
- Authors
- Kratz, F., & Elsadek, B.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 161
- Issue
- 2
- Pages
- 429-445
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1999401096
- Cited by
- 375
- References
- 72
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.